José Leal joined the Health Economics Research Centre in January 2004, having completed his MSc in Health Economics at the University of York in 2003. In 2010, José completed a doctoral thesis at the University of Oxford on the use of multi-parameter evidence synthesis to inform economic evaluations.
During his time in HERC, José has been involved on projects evaluating the economic burden of chronic diseases as well as several economic evaluations across a range of diseases.
His main research interests concern cardiovascular disease, diabetes and musculoskeletal diseases.
José is also a health economics advisor for the NIHR RDS South Central and supervises MSc and DPhil students.
Potential Value of Identifying Type 2 Diabetes Subgroups for Guiding Intensive Treatment: A Comparison of Novel Data-Driven Clustering With Risk-Driven Subgroups.
Li X. et al, (2023), Diabetes Care
Estimating the Economic Value of Automated Virtual Reality Cognitive Therapy for Treating Agoraphobic Avoidance in Patients With Psychosis: Findings From the gameChange Randomized Controlled Clinical Trial.
Altunkaya J. et al, (2022), Journal of medical Internet research, 24
Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP): a pragmatic randomised controlled trial.
Beard DJ. et al, (2022), Lancet, 400, 605 - 615
The WISDOM self-management intervention: a cost-effectiveness analysis to support the transformation of type 2 diabetes care in England.
Singh S. et al, (2022), Diabet Med
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double-blind, placebo-controlled trial.
Leal J. et al, (2022), Journal of diabetes, 14, 455 - 464